Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma
Christopoulos, P., Kirchner, M., Bozorgmehr, F., Endris, V., Elsayed, M., Budczies, J., Ristau, J., Penzel, R., Herth, F.J., Heussel, C.P., Eichhorn, M., Muley, T., Meister, M., Fischer, J.R., Rieken, S., Lasitschka, F., Bischoff, H., Sotillo, R., Schirmacher, P., Thomas, M., Stenzinger, A.
Published in International journal of cancer (01.01.2019)
Published in International journal of cancer (01.01.2019)
Get full text
Journal Article
Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer
Heigener, D.F, Deppermann, K.M, Pawel, J.v, Fischer, J.R, Kortsik, C, Bohnet, S, Eiff, M.v, Koester, W, Thomas, M, Schnabel, P.A, Reck, M
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2014)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2014)
Get full text
Journal Article
3066 Pharmacokinetically (PK)-guided dosing of paclitaxel in combination with carboplatin in advanced non-small cell lung cancer (NSCLC) is gender dependent: Updated results of the randomized CEPAC-TDM study
Joerger, M, Von Pawel, J, Kraff, S, Fischer, J.R, Gauler, T, Mueller, L, Reinmuth, N, Reck, M, Kimmich, M, Frank, M, Kopp, H.G, Behringer, D, Ko, Y.D, Ralf, H, Roessler, M, Kloft, C, Henrich, A, Moritz, B, Jaehde, U
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Docetaxel–carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)—Results of the nonrandomised phase II study TaxErb
Fischer, J.R, Griesinger, F, Fink, T, Salm, T, Marseille, A, Wolf, M
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2012)
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2012)
Get full text
Journal Article
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
Planchard, D., Reinmuth, N., Orlov, S., Fischer, J.R., Sugawara, S., Mandziuk, S., Marquez-Medina, D., Novello, S., Takeda, Y., Soo, R., Park, K., McCleod, M., Geater, S.L., Powell, M., May, R., Scheuring, U., Stockman, P., Kowalski, D.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article
9124 Phase I trial of sagopilone in combination with cisplatin as 1st-line therapy in patients with extensive-disease small-cell lung cancer (ED-SCLC)
Christoph, D.C, Gauler, T.C, Gamarra, F, Fuhr, H.G, Fischer, J.R, Gonschorek, C, Frickhofen, N, Huber, R.M, Schuler, M, Eberhardt, W.E.E
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
1442P DURATION: A multicenter randomized phase II trial investigating sequential mono- (mCTX) or doublet-chemotherapy (dCTX) followed by durvalumab (D) in older or frail patients with advanced non-small cell lung cancer (NSCLC)
Kuon, J.B., Blasi, M., Kokowski, K., Faehling, M., Schuette, W., Christoph, D.C.C., Kimmich, M., Engel-Riedel, W., Fischer, J.R., Lehmann, M., Ulmer, M., Schuett, P., Moosmann, N., Meyer zum Büschenfelde, C., Griesinger, F., Schneider, M., Behnisch, R., Stenzinger, A., Christopoulos, P., Thomas, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
Joerger, M., von Pawel, J., Kraff, S., Fischer, J.R., Eberhardt, W., Gauler, T.C., Mueller, L., Reinmuth, N., Reck, M., Kimmich, M., Mayer, F., Kopp, H.-G., Behringer, D.M., Ko, Y.-D., Hilger, R.A., Roessler, M., Kloft, C., Henrich, A., Moritz, B., Miller, M.C., Salamone, S.J., Jaehde, U.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
1570P - Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung)
Heudobler, D., Schulz, C., Fischer, J.R., Staib, P., Wehler, T., Südhoff, T., Schichtl, T., Wilke, J., Hahn, J., Lüke, F., Vogelhuber, M., Klobuch, S., Pukrop, T., Herr, W., Held, S., Beckers, K., Bouche, G., Reichle, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung)
Heudobler, D., Schulz, C., Fischer, J.R., Staib, P., Wehler, T., Südhoff, T., Schichtl, T., Wilke, J., Hahn, J., Lüke, F., Vogelhuber, M., Klobuch, S., Pukrop, T., Herr, W., Held, S., Beckers, K., Bouche, G., Reichle, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
LBA58 ORR in patients receiving nivolumab plus radiotherapy in advanced non-small cell lung cancer: First results from the FORCE trial
Bozorgmehr, F., Fischer, J.R., Bischof, M., Atmaca, A., Wetzel, S., Faehling, M., Bottke, D., Wermke, M., Troost, E.G.C., Schmidtke-Schrezenmeier, G., Wiegel, T., van Laak, V., Stupavsky, A., Engel-Riedel, W., Ingenhoff, E., Reinmuth, N., Krisam, J., Stenzinger, A., Thomas, M., Rieken, S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer
Soria, J.-C., Fülöp, A., Maciel, C., Fischer, J.R., Girotto, G., Lago, S., Smit, E., Ostoros, G., Eberhardt, W.E.E., Lishkovska, P., Lovick, S., Mariani, G., McKeown, A., Kilgour, E., Smith, P., Bowen, K., Kohlmann, A., Carlile, D.J., Jänne, P.A.
Published in Annals of oncology (01.12.2017)
Published in Annals of oncology (01.12.2017)
Get full text
Journal Article
Nivolumab Plus Low-Dose IPILIMUMAB as First-Line Treatment of Advanced NSCLC: Overall Survival Analysis of Checkmate 817
Barlesi, F., Audigier-Valette, C., Felip, E., Ciuleanu, T.-E., Jao, K., Rijavec, E., Urban, L., Aucoin, J.-S., Zannori, C., Vermaelen, K., Frontera, O. Arén, Ready, N., Curioni, A., Linardou, H., Poddubskaya, E., Fischer, J.R., Pillai, R., Li, S., Acevedo, A., Paz-Ares, L.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer
Schmittel, A., Sebastian, M., Fischer von Weikersthal, L., Martus, P., Gauler, T.C., Kaufmann, C., Hortig, P., Fischer, J.R., Link, H., Binder, D., Fischer, B., Caca, K., Eberhardt, W.E.E., Keilholz, U.
Published in Annals of oncology (01.08.2011)
Published in Annals of oncology (01.08.2011)
Get full text
Journal Article
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study
Kreuter, M., Vansteenkiste, J., Fischer, J.R., Eberhardt, W., Zabeck, H., Kollmeier, J., Serke, M., Frickhofen, N., Reck, M., Engel-Riedel, W., Neumann, S., Thomeer, M., Schumann, C., De Leyn, P., Graeter, T., Stamatis, G., Zuna, I., Griesinger, F., Thomas, M.
Published in Annals of oncology (01.04.2013)
Published in Annals of oncology (01.04.2013)
Get full text
Journal Article
Afatinib in Non‐Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors
Schumann, Christian, Sebastian, Martin, Sadjadian, Parvis, Märten, Angela, Abdollahi, A., Aries, S.P., Arntzen, C., Atmaca, A., Basara, N., Borchard, B., Bos, M., Brugger, W., Budweiser, S., Corduan, K., Cortes‐Incio, D., Dallmeier, B., Denzlinger, C., Dittrich, I., Engel‐Riedel, W., Faehling, M., Fertl, A., Fischer, J.R., Fleckenstein, D., Folprecht, G., Forstbauer, A., France, Y., Frickhofen, N., Gardizi, M., Gauler, T., Gessner, C., Gökkurt, E., Görner, M., Grah, C., Greeve, J., Greiner, J., Grohé, C., Grüning, W., Guggenberger, D., Heinrich, B., Hense, G., Hoiczyk, M., Huber, R.M., Illerhaus, G., Jacobs, G., Jung, P., Kern, J., Kersten, J., Kiehl, M., Kisro, J., Knipp, H., Ko, Y.D., Koch, J.U., Koehne, C.H., Kollmeier, J., Kommer, A., Körber, W., Krause, G., Krügel, R., Leistner, R., Liebers, U., Lommatzsch, M., Maintz, C., Mohr, M., Neumeister, W., Overbeck, T., Panse, J., Pelzer, T., Peters, K., Planker, M., Reissig, A., Ritter, M., Sadjadian, P., Sandritter, B., Schatz, M., Scheffler, M., Schmid‐Bindert, G., Schneider, C.P., Schneider‐Kappus, W., Schreiber, J., Schütte, W., Schütz, S., Sebastian, M., Serke, M., Staiger, H., Stehle, I., Stengele, K., Stöhlmacher‐Williams, J., Strapatsas, T., Sulzbach, B., Tessmer, A., Thomas, M., Ukena, D., Wagner, B., Wagner‐Hug, D., Witt, C., Wohlleber, M., Wolf, J., Wricke, K., Zaba, O., Zander, I.
Published in The oncologist (Dayton, Ohio) (01.10.2015)
Published in The oncologist (Dayton, Ohio) (01.10.2015)
Get full text
Journal Article
Real-world implementation of sequential targeted therapies for EGFR-mutated NSCLC
Christopoulos, P., Volckmar, A.-L., Bozorgmehr, F., Magios, N., Kuon, J.B., Kirchner, M., Kazdal, D., Endris, V., Bochtler, T., Herth, F.J.F., Heussel, C.-P., Winter, H., Muley, T., Meister, M., Fischer, J.R., Rieken, S., Faehling, M., Bischoff, H., Stenzinger, A., Thomas, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1538P - Real-world implementation of sequential targeted therapies for EGFR-mutated NSCLC
Christopoulos, P., Volckmar, A.-L., Bozorgmehr, F., Magios, N., Kuon, J.B., Kirchner, M., Kazdal, D., Endris, V., Bochtler, T., Herth, F.J.F., Heussel, C.-P., Winter, H., Muley, T., Meister, M., Fischer, J.R., Rieken, S., Faehling, M., Bischoff, H., Stenzinger, A., Thomas, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article